Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2005-10-18
2005-10-18
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S678000, C568S327000, C568S308000
Reexamination Certificate
active
06956061
ABSTRACT:
The present invention relates to compounds of the formula (I):which are produced by the plantGarcinia punctata, chemical derivatives derived therefrom, a process for their preparation, and their use as pharmaceuticals, in particular for the treatment and/or prophylaxis of bacterial infectious diseases.
REFERENCES:
patent: WO 03/043966 (2003-05-01), None
A. V. Rama Rao et al., Camboginol and Cambogin, Tetrahedron Letters, (1980, pp. 1795-1978, vol. 21).
John Lokvam et al., Two Polyisoprenylated Benzophenones from the trunk latex ofClusia grandiflora(Clusiaceae), Phytochemistry, (2000, pp. 29-34, vol. 55).
Richard W. Fuller et al., Guttiferone F, the First Prenylated Benzophenone fromAllanblackia Stuhlmannii, J. Nat. Prod. (1999, pp. 130-132, vol. 62).
Haag-Richter Sabine
Kurz Michael
Schiell Matthias
Aventis Pharma Deutschland GmbH
Shiao Robert
Solola Taofiq
Strupczewski Joseph
LandOfFree
Polyisoprenylbenzophenone derivatives, processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyisoprenylbenzophenone derivatives, processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyisoprenylbenzophenone derivatives, processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3487419